CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories. The FORE-SIGHT Tissue Oximeter technology provides clinicians a non-invasive, quantitative measurement of oxygenation in cerebral tissue.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:CASM
- CUSIP: N/A
- Web: www.casmed.com
Capitalization:- Market Cap: $26.78 million
- Outstanding Shares: 27,329,000
Average Prices:- 50 Day Moving Avg: $1.12
- 200 Day Moving Avg: $1.24
- 52 Week Range: $0.80 - $1.94
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -5.76
- P/E Growth: -0.24
Sales & Book Value:- Annual Revenue: $22.24 million
- Price / Sales: 1.20
- Book Value: ($0.49) per share
- Price / Book: -2.00
Profitability:- EBIDTA: ($4,050,000.00)
- Net Margins: -32.59%
- Return on Assets: -47.68%
Debt:- Debt-to-Equity Ratio: -0.48%
- Current Ratio: 1.86%
- Quick Ratio: 1.62%
Misc:- Average Volume: 57,750 shs.
- Beta: -1.17
- Short Ratio: 5.07
Frequently Asked Questions for CAS Medical Systems (NASDAQ:CASM)
What is CAS Medical Systems' stock symbol?
CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."
How were CAS Medical Systems' earnings last quarter?
CAS Medical Systems, Inc. (NASDAQ:CASM) released its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The business earned $4.57 million during the quarter, compared to the consensus estimate of $5.41 million. View CAS Medical Systems' Earnings History.
When will CAS Medical Systems make its next earnings announcement?
Who are some of CAS Medical Systems' key competitors?
Some companies that are related to CAS Medical Systems include Electromed (ELMD), Biolase (BIOL), Presbia PLC (LENS), Luna Innovations Incorporated (LUNA), Invivo Therapeutics Holdings Corp (NVIV), EnteroMedics (ETRM), Advanced Oncotherapy PLC (AVO), Xtant Medical Holdings (XTNT), Dynatronics Corporation (DYNT), Sphere Medical Holding PLC (SPHR), Dextera Surgical (DXTR), PhotoMedex (PHMD), BIOLASE (BLTI), Cynosure (CYNO), Derma Sciences (DSCI), Hansen Medical (HNSN), Lifeline Scientific (LSIC) and Mindray Medical International Ltd (MR).
Who are CAS Medical Systems' key executives?
CAS Medical Systems' management team includes the folowing people:
- Thomas M. Patton, President, Chief Executive Officer, Director
- Jeffrey A. Baird, Chief Financial Officer, Secretary
- Kimberly K. Strusky, Executive Vice President - U.S. Sales
- Paul B. Benni, Chief Scientific Officer
- John R. Gamelin Ph.D., Vice President - Research & Development
- James E. Thomas, Lead Independent Director
- Alan W. Milinazzo, Director
- Paul A. Molloy, Director
- Gregory P. Rainey, Independent Director
- Kathleen A. Tune, Independent Director
Who owns CAS Medical Systems stock?
CAS Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include Stonepine Capital Management LLC (3.29%), Vanguard Group Inc. (1.88%) and HighTower Advisors LLC (0.90%). View Institutional Ownership Trends for CAS Medical Systems.
Who bought CAS Medical Systems stock? Who is buying CAS Medical Systems stock?
How do I buy CAS Medical Systems stock?
Shares of CAS Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CAS Medical Systems' stock price today?
One share of CAS Medical Systems stock can currently be purchased for approximately $0.98.
MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for CAS Medical Systems (NASDAQ:CASM) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for CAS Medical Systems (NASDAQ:CASM)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CAS Medical Systems (NASDAQ:CASM)Earnings History by Quarter for CAS Medical Systems (NASDAQ CASM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/6/2017 | | ($0.06) | | | | | N/A |  |
| 8/8/2017 | Q2 2017 | ($0.07) | ($0.09) | $5.41 million | $4.57 million | View | Listen | |
| 5/3/2017 | Q1 2017 | ($0.06) | ($0.08) | $5.73 million | $5.23 million | View | Listen | |
| 3/9/2017 | Q4 2016 | ($0.03) | ($0.07) | $5.49 million | $5.48 million | View | Listen | |
| 11/8/2016 | Q3 | ($0.05) | ($0.06) | $5.85 million | $5.76 million | View | Listen | |
| 8/4/2016 | Q2 | ($0.05) | ($0.08) | $5.58 million | $5.50 million | View | N/A | |
| 5/5/2016 | Q1 | ($0.06) | ($0.03) | $5.88 million | $5.46 million | View | N/A | |
| 3/9/2016 | Q4 | ($0.07) | ($0.08) | $5.20 million | $5.80 million | View | Listen | |
| 11/5/2015 | Q315 | ($0.09) | ($0.08) | $5.66 million | $5.50 million | View | N/A | |
| 8/5/2015 | Q215 | ($0.10) | ($0.09) | $5.36 million | $5.80 million | View | N/A | |
| 5/5/2015 | Q115 | ($0.10) | ($0.08) | $5.21 million | $5.80 million | View | N/A | |
| 3/4/2015 | Q414 | ($0.11) | ($0.11) | $5.80 million | $5.80 million | View | N/A | |
| 11/4/2014 | Q3 2014 | ($0.12) | ($0.10) | | $5.53 million | View | N/A | |
| 8/6/2014 | Q214 | ($0.11) | ($0.11) | $5.00 million | $5.80 million | View | N/A | |
| 5/1/2014 | Q1 2014 | ($0.13) | ($0.11) | | $5.71 million | View | N/A | |
| 3/6/2014 | Q413 | ($0.17) | ($0.19) | $5.90 million | $5.90 million | View | N/A | |
| 11/12/2013 | Q3 | | ($0.19) | $6.10 million | $5.40 million | View | Listen | |
| 8/7/2013 | Q2 2013 | | ($0.22) | $5.20 million | $5.00 million | View | N/A | |
| 5/8/2013 | Q1 2013 | | ($0.14) | | | View | N/A | |
| 11/8/2012 | Q312 | | ($0.14) | $5.79 million | $6.11 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for CAS Medical Systems (NASDAQ:CASM)2017 EPS Consensus Estimate: ($0.31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.07) | ($0.07) | ($0.07) |
| Q2 2017 | 1 | ($0.06) | ($0.06) | ($0.06) |
| Q3 2017 | 1 | ($0.09) | ($0.09) | ($0.09) |
| Q4 2017 | 1 | ($0.09) | ($0.09) | ($0.09) |
(Data provided by Zacks Investment Research)
Dividend History for CAS Medical Systems (NASDAQ:CASM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for CAS Medical Systems (NASDAQ:CASM)Insider Ownership Percentage: 34.10%
Institutional Ownership Percentage: 26.71%
Insider Trades by Quarter for CAS Medical Systems (NASDAQ:CASM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 1/26/2017 | James E Flynn | Insider | Sell | 636,238 | $1.46 | $928,907.48 | |
| 1/23/2017 | James E Flynn | Insider | Sell | 205,126 | $1.53 | $313,842.78 | |
| 5/15/2015 | Brian J Wagner | Insider | Buy | 2,032 | $1.31 | $2,661.92 | |
| 2/11/2015 | Thomas M Patton | CEO | Buy | 40,000 | $1.30 | $52,000.00 | |
| 2/11/2015 | Thomas, Mcnerney & Partners Ii | Major Shareholder | Buy | 1,605,000 | $1.30 | $2,086,500.00 | |
| 9/2/2014 | Thomas M Patton | CEO | Buy | 1,500 | $1.48 | $2,220.00 | |
| 8/18/2014 | Thomas M Patton | CEO | Buy | 10,000 | $1.54 | $15,400.00 | |
| 8/8/2014 | Thomas M Patton | CEO | Buy | 10,000 | $1.61 | $16,100.00 | |
| 8/21/2013 | Thomas M Patton | CEO | Buy | 5,300 | $1.42 | $7,526.00 | |
| 9/6/2012 | Thomas M Patton | CEO | Buy | 10,332 | $1.88 | $19,424.16 | |
(Data available from 1/1/2013 forward)
Headline Trends for CAS Medical Systems (NASDAQ:CASM)
Latest Headlines for CAS Medical Systems (NASDAQ:CASM)
| Source: |
|
| Date | Headline |
|---|
 | Zacks Investment Research Comments on CAS Medical Systems, Inc.'s Q3 2017 Earnings (CASM)
www.americanbankingnews.com - August 17 at 8:38 AM |
 | CASM: Clinical Superiority, Productivity Gains Bode Well For Growth Inflection
finance.yahoo.com - August 15 at 5:44 PM |
| CAS Medical Systems, Inc. (CASM) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 9 at 5:56 PM |
| Edited Transcript of CASM earnings conference call or presentation 8-Aug-17 2:00pm GMT
finance.yahoo.com - August 9 at 2:46 AM |
| CASMED Reports Second-Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 4:44 PM |
| CASMED to Report Second-Quarter 2017 Financial Results and Hold Conference Call on August 8
finance.yahoo.com - August 1 at 5:43 PM |
| CASMED Sells Non-invasive Blood Pressure Monitoring Product Line to SunTech Medical
finance.yahoo.com - July 26 at 5:31 PM |
| CAS Medical Systems, Inc. (CASM) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 26 at 7:56 AM |
| ETFs with exposure to CAS Medical Systems, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 5:57 PM |
| ETFs with exposure to CAS Medical Systems, Inc. : June 27, 2017
finance.yahoo.com - June 27 at 4:22 PM |
| ETFs with exposure to CAS Medical Systems, Inc. : June 16, 2017
finance.yahoo.com - June 16 at 4:54 PM |
| CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 4:56 PM |
| CASM: Expect Salesforce Productivity, Revenue Acceleration in 2H
finance.yahoo.com - May 8 at 9:07 PM |
| CAS Medical Systems Inc (CASM) Releases Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - May 4 at 9:00 PM |
 | CAS Medical Systems' (CASM) CEO Tom Patton on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 7:30 PM |
| Investor Network: CAS Medical Systems, Inc. to Host Earnings Call
finance.yahoo.com - May 3 at 7:30 PM |
| CASMED Reports First-Quarter 2017 Financial Results
finance.yahoo.com - May 3 at 7:30 PM |
| CASMED to Report First-Quarter 2017 Financial Results and Hold Conference Call on May 3
finance.yahoo.com - April 26 at 2:59 PM |
| ETFs with exposure to CAS Medical Systems, Inc. : April 20, 2017
finance.yahoo.com - April 20 at 4:16 PM |
| CAS MEDICAL SYSTEMS INC Financials
finance.yahoo.com - March 21 at 4:28 PM |
| CASM: 2017 Shaping Up To Be Another Record Year
finance.yahoo.com - March 15 at 4:30 PM |
| Edited Transcript of CASM earnings conference call or presentation 9-Mar-17 3:00pm GMT
finance.yahoo.com - March 10 at 2:46 AM |
| Q4 2016 CAS Medical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - March 9 at 9:44 PM |
 | CASMED Reports 2016 Fourth-Quarter and Full-Year Financial Results
globenewswire.com - March 9 at 4:43 PM |
| CAS Medical Systems' (CASM) CEO Tom Patton on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 9 at 4:43 PM |
| CASMED to Report Fourth-Quarter and 2016 Full-Year Financial Results and Hold Conference Call on March 9
finance.yahoo.com - March 2 at 4:20 PM |
| CAS Medical Systems: Double-Digit Top-line Organic Growth, Recurring Revenue Razor-Razorblade, Medical Technology Business
seekingalpha.com - February 15 at 2:55 AM |
| CASM: Q4 Revenue Growth of 14%, Further Acceleration in 2H 2017
finance.yahoo.com - January 13 at 4:53 PM |
| CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - January 10 at 4:51 PM |
| 8:11 am CAS Medical offers prelim Q4 revs results, discusses FY17 outlook
finance.yahoo.com - January 10 at 4:51 PM |
| CASM: Share Gains, Market Expansion Driving Double-Digit Revenue Growth
finance.yahoo.com - November 15 at 4:20 PM |
| Intracranial Pressure Monitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
finance.yahoo.com - November 14 at 9:38 PM |
| Edited Transcript of CASM earnings conference call or presentation 8-Nov-16 3:00pm GMT
finance.yahoo.com - November 9 at 1:23 PM |
| CASMED to Present at Craig-Hallum Alpha Select Conference
finance.yahoo.com - November 9 at 1:23 PM |
| Medical Systems' (CASM) CEO Tom Patton on Q3 2016 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 9:44 PM |
| CASMED to Report Third-Quarter 2016 Financial Results and Hold Conference Call on November 8
finance.yahoo.com - November 2 at 10:58 AM |
| CASM: FORE-SIGHT Sensor Sales Driving Rapid Revenue Growth, Expanding Margins
finance.yahoo.com - August 8 at 4:07 PM |
| Edited Transcript of CASM earnings conference call or presentation 4-Aug-16 2:00pm GMT
finance.yahoo.com - August 5 at 12:29 PM |
| CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-B
biz.yahoo.com - July 5 at 7:00 AM |
| CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 23 at 3:03 PM |
 | Intracranial Pressure Monitors Market to Reach US$ 1.63 Bn by 2023; Led by Consistent Rise in Health Care Spending in Developed Countries - TMR
www.bizjournals.com - June 17 at 11:57 AM |
| CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
biz.yahoo.com - May 5 at 8:01 AM |
| Q1 2016 CAS Medical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 5 at 7:07 AM |
| CAS MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 2:03 PM |
| CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements
biz.yahoo.com - March 29 at 4:07 PM |
| Edited Transcript of CASM earnings conference call or presentation 9-Mar-16 3:00pm GMT
finance.yahoo.com - March 9 at 5:09 PM |
| CAS Medical Systems Inc Earnings Call scheduled for 10:00 am ET today
biz.yahoo.com - March 9 at 10:00 AM |
CAS Medical Systems (CASM) Chart for Monday, August, 21, 2017
